Rossi Alessandra, Belmonte Beatrice, Carnevale Silvia, Liotti Antonietta, De Rosa Veronica, Jaillon Sebastien, Piconese Silvia, Tripodo Claudio
Department of Internal Clinical Sciences, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Tumor Immunology Unit, Department of Sciences for Health Promotion and Mother-Child Care "G. D'Alessandro", University of Palermo, Palermo, Italy.
Front Cell Dev Biol. 2022 Jul 8;10:933113. doi: 10.3389/fcell.2022.933113. eCollection 2022.
Tertiary lymphoid structures (TLS) are ectopic lymphoid organs that have been observed in chronic inflammatory conditions including cancer, where they are thought to exert a positive effect on prognosis. Both immune and non-immune cells participate in the genesis of TLS by establishing complex cross-talks requiring both soluble factors and cell-to-cell contact. Several immune cell types, including T follicular helper cells (Tfh), regulatory T cells (Tregs), and myeloid cells, may accumulate in TLS, possibly promoting or inhibiting their development. In this manuscript, we propose to review the available evidence regarding specific aspects of the TLS formation in solid cancers, including 1) the role of stromal cell composition and architecture in the recruitment of specific immune subpopulations and the formation of immune cell aggregates; 2) the contribution of the myeloid compartment (macrophages and neutrophils) to the development of antibody responses and the TLS formation; 3) the immunological and metabolic mechanisms dictating recruitment, expansion and plasticity of Tregs into T follicular regulatory cells, which are potentially sensitive to immunotherapeutic strategies directed to costimulatory receptors or checkpoint molecules.
三级淋巴结构(TLS)是异位淋巴器官,在包括癌症在内的慢性炎症条件下已被观察到,人们认为它们对预后具有积极影响。免疫细胞和非免疫细胞都通过建立需要可溶性因子和细胞间接触的复杂相互作用来参与TLS的形成。几种免疫细胞类型,包括滤泡辅助性T细胞(Tfh)、调节性T细胞(Tregs)和髓样细胞,可能在TLS中积聚,可能促进或抑制其发育。在本手稿中,我们建议回顾关于实体癌中TLS形成特定方面的现有证据,包括:1)基质细胞组成和结构在特定免疫亚群募集和免疫细胞聚集体形成中的作用;2)髓样区室(巨噬细胞和中性粒细胞)对抗体反应发展和TLS形成的贡献;3)决定Tregs募集、扩增和向滤泡调节性T细胞可塑性的免疫和代谢机制,这些机制可能对针对共刺激受体或检查点分子的免疫治疗策略敏感。